Skip to Main Content

Author Details

Carme Camps
National Institute for Health Research Biomedical Research Centre
2004
28
22
PMIDPaper TitleJournal TitlePublished Year
34716541Future care for long-term cancer survivors: towards a new model.Clin Transl Oncol2022
34758253100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.N Engl J Med2021
34860543FOXN1 forms higher-order nuclear condensates displaced by mutations causing immunodeficiency.Sci Adv2021
31358947The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom.Genet Med2020
32642185Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q.J Thorac Dis2020
30685599A translational approach to design effective intervention tools for informal caregivers of dependent cancer patients.Public Health2019
30042065Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.Lancet Gastroenterol Hepatol2018
29891534Identification of a new <i>VHL</i> exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease.Blood2018
28196074Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.PLoS Med2017
27651169Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.Haematologica2016
27626278Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis.PLoS One2016
25417700Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival.Oncogene2015
26289678Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival.Oncogene2015
24363272Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2.EMBO Rep2014
24517586Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia.Mol Cancer2014
23390484TGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos.PLoS One2013
24209638MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.BMC Cancer2013
22562984Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model.Ann Rheum Dis2012
21407217The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.Br J Cancer2011
21737487microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer.Cancer Res2011
20214702Spanish nephrology nurses' views and attitudes towards caring for dying patients.J Ren Care2010
20187102hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.Cancer2010
18854420A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.Am J Physiol Endocrinol Metab2009
19689793MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes.BMC Med Genomics2009
18316553hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.Clin Cancer Res2008
18948893MicroRNA-10b and breast cancer metastasis.Nature2008
15811009X-linked adrenoleukodystrophy in Spain. Identification of 26 novel mutations in the ABCD1 gene in 80 patients. Improvement of genetic counseling in 162 relative females.Clin Genet2005
15489218Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy.Hum Mol Genet2004
  • 1 - 28 of 28

Recommended Authors

Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Asha A Nair
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 4
Magdalena Niemira
Clinical Research Centre, Medical University of Bialystok
Career Start Year 2009
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 0
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 0
Lana X Garmire
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 0
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 1
Francesca Rizzo
University of Salerno and Genome Research Center for Health
Career Start Year 2004
Number of shared co-authors 0
Emiliano Dalla
University of Udine
Career Start Year 2002
Number of shared co-authors 1
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 1
Keyue Ding
Queen's University
Career Start Year 2002
Number of shared co-authors 0
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 0
Joanne B Weidhaas
University of California-Los Angeles
Career Start Year 2000
Number of shared co-authors 1
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 0
John Le Quesne
Beatson Cancer Research Institute, University of Glasgow
Career Start Year 1998
Number of shared co-authors 1
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
Muneesh Tewari
University of Michigan ann arbor
Career Start Year 1995
Number of shared co-authors 1
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 1
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Mircea Ivan
Indiana University School of Medicine
Career Start Year 1993
Number of shared co-authors 4
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 11
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1

Collaborators

Jiannis Ragoussis
McGill University
Co-authored papers 13
Adrian L Harris
University of Oxford
Co-authored papers 9
Francesca M Buffa
University of Oxford
Co-authored papers 8
Jenny C Taylor
University of Oxford
Co-authored papers 8
Peter J Ratcliffe
Co-authored papers 4
Sarah Wordsworth
Health Economics Research Centre, University of Oxford
Co-authored papers 3
Catharine M L West
University of Manchester
Co-authored papers 2
John Taylor
Oxford University Hospitals NHS Foundation Trust, Churchill Hospital
Co-authored papers 2
James Buchanan
Health Economics Research Centre, University of Oxford
Co-authored papers 2
Daniela Moralli
Co-authored papers 2
Alistair T Pagnamenta
NIHR Biomedical Research Centre, University of Oxford
Co-authored papers 2
Syed Haider
Institute of Cancer Research
Co-authored papers 2
Claire Palles
Institute of Cancer and Genomic Sciences, University of Birmingham
Co-authored papers 2
Erika Kvikstad
University of Oxford
Co-authored papers 2
Philip Twiss
Cambridge University Hospitals NHS Foundation Trust
Co-authored papers 1
Stephanie Grunewald
Great Ormond Street Hospital for Children NHS Trust
Co-authored papers 1
Francesco Muntoni
UCL Great Ormond Street Institute of Child Health
Co-authored papers 1
Antonio Rueda Martin
Queen Mary University of London
Co-authored papers 1
Dragana Josifova
Guy's and St Thomas' Hospital
Co-authored papers 1
Douglass M Turnbull
Newcastle University
Co-authored papers 1
Valentina Cipriani
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 1
Christopher Boustred
Co-authored papers 1
Anna de Burca
Oxford University Hospitals NHS Foundation Trust
Co-authored papers 1
Charu Deshpande
Guy's Hospital
Co-authored papers 1
Bishoy Habib
Co-authored papers 1
Gr??inne S Gorman
Newcastle upon Tyne Hospitals NHS Foundation Trust
Co-authored papers 1
Dominic J McMullan
Birmingham Women's and Children's NHS Foundation Trust
Co-authored papers 1
No??mi B A Roy
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Co-authored papers 1
Sarju G Mehta
Cambridge University Hospitals NHS Foundation Trust
Co-authored papers 1
Opher Gileadi
Structural Genomics Consortium Karolinska Institute Stockholm Sweden.
Co-authored papers 1
Release 1.2